These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 31325480)
1. BRD4 contributes to high-glucose-induced podocyte injury by modulating Keap1/Nrf2/ARE signaling. Zuo H; Wang S; Feng J; Liu X Biochimie; 2019 Oct; 165():100-107. PubMed ID: 31325480 [TBL] [Abstract][Full Text] [Related]
2. Sulfiredoxin-1 alleviates high glucose-induced podocyte injury though promoting Nrf2/ARE signaling via inactivation of GSK-3β. Shen Y; Chen S; Zhao Y Biochem Biophys Res Commun; 2019 Sep; 516(4):1137-1144. PubMed ID: 31284950 [TBL] [Abstract][Full Text] [Related]
3. Perilipin 5 ameliorates high-glucose-induced podocyte injury via Akt/GSK-3β/Nrf2-mediated suppression of apoptosis, oxidative stress, and inflammation. Feng J; Xie L; Yu X; Liu C; Dong H; Lu W; Kong R Biochem Biophys Res Commun; 2021 Mar; 544():22-30. PubMed ID: 33516878 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of SETD6 protects podocyte against high glucose and palmitic acid-induced apoptosis, and mitochondrial dysfunction via activating Nrf2-Keap1 signaling pathway in diabetic nephropathy. Wang X; Liu Q; Kong D; Long Z; Guo Y; Wang S; Liu R; Hai C J Mol Histol; 2020 Oct; 51(5):549-558. PubMed ID: 32803470 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-146b-5p protects oligodendrocyte precursor cells from oxygen/glucose deprivation-induced injury through regulating Keap1/Nrf2 signaling via targeting bromodomain-containing protein 4. Li X; Zhang W; Xiao M; Wang F; Zhou P; Yang J; Chen X Biochem Biophys Res Commun; 2019 Jun; 513(4):875-882. PubMed ID: 31003769 [TBL] [Abstract][Full Text] [Related]
6. Klotho ameliorates diabetic nephropathy by activating Nrf2 signaling pathway in podocytes. Xing L; Guo H; Meng S; Zhu B; Fang J; Huang J; Chen J; Wang Y; Wang L; Yao X; Wang H Biochem Biophys Res Commun; 2021 Jan; 534():450-456. PubMed ID: 33256980 [TBL] [Abstract][Full Text] [Related]
7. Astragaloside IV attenuates podocyte apoptosis through ameliorating mitochondrial dysfunction by up-regulated Nrf2-ARE/TFAM signaling in diabetic kidney disease. Shen Q; Fang J; Guo H; Su X; Zhu B; Yao X; Wang Y; Cao A; Wang H; Wang L Free Radic Biol Med; 2023 Jul; 203():45-57. PubMed ID: 37030337 [TBL] [Abstract][Full Text] [Related]
8. CKIP-1 affects the polyubiquitination of Nrf2 and Keap1 via mediating Smurf1 to resist HG-induced renal fibrosis in GMCs and diabetic mice kidneys. Gong W; Chen Z; Zou Y; Zhang L; Huang J; Liu P; Huang H Free Radic Biol Med; 2018 Feb; 115():338-350. PubMed ID: 29248720 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of USP15 ameliorates high-glucose-induced oxidative stress and inflammatory injury in podocytes through regulation of the Keap1/Nrf2 signaling. Xu E; Yin C; Yi X; Liu Y Environ Toxicol; 2022 Apr; 37(4):765-775. PubMed ID: 34931430 [TBL] [Abstract][Full Text] [Related]
10. TRIM32 Inhibition Attenuates Apoptosis, Oxidative Stress, and Inflammatory Injury in Podocytes Induced by High Glucose by Modulating the Akt/GSK-3β/Nrf2 Pathway. Chen Z; Tian L; Wang L; Ma X; Lei F; Chen X; Fu R Inflammation; 2022 Jun; 45(3):992-1006. PubMed ID: 34783942 [TBL] [Abstract][Full Text] [Related]
11. Solasonine alleviates high glucose-induced podocyte injury through increasing Nrf2-medicated inhibition of NLRP3 activation. Zhang Q; Hu Y; Hu JE; Zhang M Drug Dev Res; 2022 Nov; 83(7):1697-1706. PubMed ID: 36048966 [TBL] [Abstract][Full Text] [Related]
12. Activation of Akt-dependent Nrf2/ARE pathway by restoration of Brg-1 remits high glucose-induced oxidative stress and ECM accumulation in podocytes. Yan H; Xu F; Xu J; Song MA; Wang K; Wang L J Biochem Mol Toxicol; 2021 Mar; 35(3):e22672. PubMed ID: 33270355 [TBL] [Abstract][Full Text] [Related]
13. PHLPP2 downregulation protects cardiomyocytes against hypoxia-induced injury through reinforcing Nrf2/ARE antioxidant signaling. Jin A; Li B; Li W; Xiao D Chem Biol Interact; 2019 Dec; 314():108848. PubMed ID: 31610156 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of PHLPP1 ameliorates high glucose-evoked injury in retinal ganglion cells by attenuating apoptosis and oxidative stress through enhancement of Nrf2 activation. Zhang X; Lu Y; He N; Wang F Exp Cell Res; 2020 Dec; 397(2):112344. PubMed ID: 33164862 [TBL] [Abstract][Full Text] [Related]
15. Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway. Lv C; Cheng T; Zhang B; Sun K; Lu K Ren Fail; 2023 Dec; 45(1):2165103. PubMed ID: 36938748 [No Abstract] [Full Text] [Related]
16. Inhibition of bromodomain-containing protein 4 ameliorates oxidative stress-mediated apoptosis and cartilage matrix degeneration through activation of NF-E2-related factor 2-heme oxygenase-1 signaling in rat chondrocytes. An QD; Li YY; Zhang HX; Lu J; Yu XD; Lin Q; Zhang YG J Cell Biochem; 2018 Sep; 119(9):7719-7728. PubMed ID: 29878401 [TBL] [Abstract][Full Text] [Related]
17. Protective effects of klotho on palmitate-induced podocyte injury in diabetic nephropathy. Suk Kang J; Son SS; Lee JH; Lee SW; Jeong AR; Lee ES; Cha SK; Chung CH; Lee EY PLoS One; 2021; 16(4):e0250666. PubMed ID: 33891667 [TBL] [Abstract][Full Text] [Related]
18. Sp1-mediated upregulation of Prdx6 expression prevents podocyte injury in diabetic nephropathy via mitigation of oxidative stress and ferroptosis. Zhang Q; Hu Y; Hu JE; Ding Y; Shen Y; Xu H; Chen H; Wu N Life Sci; 2021 Aug; 278():119529. PubMed ID: 33894270 [TBL] [Abstract][Full Text] [Related]
19. SP600125 suppresses Zhang H; Liu X; Zhou S; Jia Y; Li Y; Song Y; Wang J; Wu H J Mol Endocrinol; 2018 Feb; 60(2):145-157. PubMed ID: 29273684 [TBL] [Abstract][Full Text] [Related]
20. Senescence marker protein 30 confers neuroprotection in oxygen-glucose deprivation/reoxygenation-injured neurons through modulation of Keap1/Nrf2 signaling: Role of SMP30 in OGD/R-induced neuronal injury. Liu W; Zhao H; Su Y; Wang K; Li J; Xue S; Sun X; Qiu Z Hum Exp Toxicol; 2021 Mar; 40(3):472-482. PubMed ID: 32909858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]